rs121917765
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PM1PM2PP3_StrongPP5_Moderate
The ENST00000352909.8(TH):c.983G>T(p.Cys328Phe) variant causes a missense change. The variant allele was found at a frequency of 0.00000069 in 1,449,594 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★). Synonymous variant affecting the same amino acid position (i.e. C328C) has been classified as Likely benign.
Frequency
Consequence
ENST00000352909.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TH | NM_000360.4 | c.983G>T | p.Cys328Phe | missense_variant | 9/13 | ENST00000352909.8 | NP_000351.2 | |
TH | NM_199292.3 | c.1076G>T | p.Cys359Phe | missense_variant | 10/14 | NP_954986.2 | ||
TH | NM_199293.3 | c.1064G>T | p.Cys355Phe | missense_variant | 10/14 | NP_954987.2 | ||
TH | XM_011520335.3 | c.995G>T | p.Cys332Phe | missense_variant | 9/13 | XP_011518637.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TH | ENST00000352909.8 | c.983G>T | p.Cys328Phe | missense_variant | 9/13 | 1 | NM_000360.4 | ENSP00000325951 | P1 |
Frequencies
GnomAD3 genomes Cov.: 34
GnomAD4 exome AF: 6.90e-7 AC: 1AN: 1449594Hom.: 0 Cov.: 32 AF XY: 0.00000139 AC XY: 1AN XY: 720526
GnomAD4 genome Cov.: 34
ClinVar
Submissions by phenotype
Autosomal recessive DOPA responsive dystonia Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Apr 14, 2022 | Variant summary: TH c.1076G>T (p.Cys359Phe) results in a non-conservative amino acid change located in the Aromatic amino acid hydroxylase, C-terminal domain (IPR019774) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 217992 control chromosomes. c.1076G>T has been reported in the literature as a homozygous genotype in at-least one individual affected with Tyrosine Hydroxylase Deficiency and continues to be reported/cited by others (example, Brautigam_1999, Dionisi-Vici_2000, Hoffmann_2003, Dong_2020). These data indicate that the variant may be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function (Fossbakk_2014). The most pronounced variant effect results in severely reduced activity compared with wt TH ( 10%), and significantly altered affinities for both tyrosine and the cofactor BH4. Interestingly, this mutation led to a higher selectivity for L-Tyrosine. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as likely pathogenic. - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Dec 01, 1999 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at